Response to letter to the editor referencing-2016 updated MASCC/ESMO consensus recommendations: management of nausea and vomiting in advanced cancer.

Ripamonti, Carla I; Davies, Andrew; Bruera, Eduardo; Molassiotis, Alex; Walsh, Declan

Ripamonti, Carla I; Davies, Andrew; Bruera, Eduardo; Molassiotis, Alex; Walsh, Declan.

Afiliação

Ripamonti CI; Oncology-Supportive Care in Cancer Unit; Department Onco-Haematology, Fondazione IRCCS, Istituto Nazionale dei Tumori, Milan, Italy. Carla.Ripamonti@istitutotumori.mi.it.
Davies A; Supportive & Palliative Care Department, Royal Surrey County Hospital/St.Luke's Cancer Centre, Guildford, UK.
Bruera E; Department of Palliative, Rehabilitation, & Integrative Medicine UT, MD Anderson Cancer Center, Houston, TX, USA.
Molassiotis A; School of Nursing, The Hong Kong Polytechnic University, Hong Kong, China.
Walsh D; Department of Supportive Oncology, Levine Cancer Institute, Charlotte, North Carolina, USA.

Support Care Cancer ; 25(10): 2991-2992, 2017 10.

Article em En | MEDLINE | ID: mdl-28785861

Assuntos

Consenso; Náusea; Antieméticos; Antineoplásicos; Humanos; Neoplasias; Vômito

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Consenso / Náusea Idioma: En Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Itália

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google